News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cortria Corporation Appoints Dennis H. Giesing, Ph.D., Former Worldwide Head of Lead Optimization at Aventis Pharmaceuticals, Inc. (AVE), as Head of Research and Development



12/9/2008 9:33:51 AM

BOSTON--(BUSINESS WIRE)--Cortria Corporation today announced the appointment of Dennis H. Giesing, Ph.D., as Head of Research and Development. Dr. Giesing brings over thirty years of experience in pharmaceutical drug development, most recently at Aventis Pharmaceuticals where he had worldwide responsibility for the Aventis R&D product pipeline from late discovery through early clinical development.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES